Total planned funding: $686,538,406
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $686,538,406 |
Organizational Types
NGO | $221,036,011 |
Private Contractor | $149,783,813 |
Unknown | $87,669,249 |
University | $83,750,840 |
Own Agency | $72,494,970 |
Implementing Agency | $49,061,524 |
FBO | $21,175,999 |
Other USG Agency | $1,016,000 |
Host Country Government Agency | $500,000 |
Multi-lateral Agency | $50,000 |
Program Areas
Treatment | $230,261,220 |
Prevention | $173,100,952 |
Care | $151,290,878 |
Testing | $51,179,171 |
Management and Operations | $40,455,891 |
Governance and Systems | $40,250,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $151,456,611 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $96,008,717 |
HKID: Care: Orphans and Vulnerable Children | $85,920,108 |
HTXD: Treatment: ARV Drugs | $71,083,442 |
HVCT: Testing: HIV Testing and Counseling | $51,179,171 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,118,012 |
HVMS: Management and Operations | $40,455,891 |
HBHC: Care: Adult Care and Support | $34,715,381 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $23,184,882 |
HVTB: Care: TB/HIV | $19,816,724 |
OHSS: Health Systems Strengthening | $18,678,723 |
HVSI: Strategic Information | $13,845,422 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,789,341 |
PDCS: Care: Pediatric Care and Support | $10,838,665 |
HLAB: Laboratory Infrastructure | $7,726,149 |
PDTX: Treatment: Pediatric Treatment | $7,721,167 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$127,923,922
Countries/Regions
University of Washington:
$93,644,664
Countries/Regions
Not Available:
$85,470,672
Countries/Regions
FHI 360:
$53,072,198
Countries/Regions